Novolin R Sq (regular Insulin)

  • Uploaded by: E
  • 0
  • 0
  • October 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Novolin R Sq (regular Insulin) as PDF for free.

More details

  • Words: 720
  • Pages: 3
NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name Trade Name Classification regular insulin Humulin R, Novolin R antidiabetics Peak Onset Duration 2-4 hr 30-60 min 5-7 hr Why is your patient getting this medication Diabetes mellitus

Mechanism of action and indications (Why med ordered) Lower blood glucose by increasing transport into cells and promoting the conversion of glucose to glycogen. Promote the conversion of amino acids to proteins in muscle and stimulate triglyceride formation. Inhibit the release of free fatty acids.

Dose Route Time/frequency (BS -100)/40 = SQ Fingerstick blood sugar units of insulin checks q AC & HS Normal dosage range 0.5-1 unit/kg/day For IV meds, compatibility with IV drips and/or solutions Medication errors involving insulins have resulted in serious patient harm and death. Clarify all ambiguous orders and do not accept orders using the abbreviation "u" for units, which can be misread as a zero or the numeral 4 and has resulted in tenfold overdoses. Insulins are available in different types and strengths and from different species. Check type, species source, dose, and expiration date with another licensed nurse. Do not interchange insulins without consulting physician or other health care professional. Do not confuse regular concentrated (U-500) insulin with regular insulin. Use only insulin syringes to draw up dose. The unit markings on the insulin syringe must match the insulin's units/ml. Special syringes for doses <50 units are available. Prior to withdrawing dose, rotate vial between palms to ensure uniform solution; do not shake. When mixing insulins, draw regular insulin or insulin lispro into syringe first to avoid contamination of regular insulin vial. Insulin should be stored in a cool place but does not need to be refrigerated. If unable to refrigerate, the 10- ml vial can be kept in a cool place unrefrigerated for up to 28 days, and the 5-ml vial, up to 14 days. Nursing Implications (what to focus on) Contraindications/warnings/interactions Allergy or hypersensitivity to a particular type of insulin, preservatives, or other additives, stress, infection (temporarily increase insulin requirements). Common side effects Lipodystrophy, HYPOGLYCEMIA.

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) Beta blockers may block some of the signs and symptoms of hypoglycemia and delay recovery from hypoglycemia (Coreg). Chronic use of alcohol may increase insulin requirements. Acute use of alcohol and beta blockers (nonselective) may decrease insulin requirements. Oral hypoglycemic agents (Glucophage) may ↓ insulin requirements.

Nursing Process- Assessment (Pre-administration assessment) Blood sugar monitoring. Assess for signs and symptoms of hypoglycemia (anxiety; chills; cold sweats; confusion; cool, pale skin; difficulty in concentration; drowsiness; excessive hunger; headache; irritability; nausea; nervousness; rapid pulse; shakiness; unusual tiredness or weakness) and hyperglycemia (drowsiness; flushed, dry skin; fruit-like breath odor; frequent urination; loss of appetite; tiredness; unusual thirst) periodically during therapy. Monitor body weight periodically. Changes in weight may necessitate changes in insulin dose.

Lab value alterations caused by medicine May cause ↓ serum inorganic phosphate, magnesium, and potassium levels. Be sure to teach the patient the following about this medication Instruct patient on proper technique for administration. Include type of insulin, equipment (syringe, cartridge pens, external pumps, alcohol swabs), storage, and place to discard syringes. Discuss the importance of not changing brands of insulin or syringes, selection and rotation of injection sites, and compliance with therapeutic regimen. Explain to patient that this medication controls hyperglycemia but does not cure diabetes. Therapy is long term. Emphasize the importance of compliance with nutritional guidelines and regular exercise as directed by health care professional. Advise patient to notify health care professional of medication regimen prior to treatment or surgery. Advise patient to notify health care professional if nausea, vomiting, or fever develops, if unable to eat regular diet, or if blood glucose levels are not controlled. Instruct patient on signs and symptoms of hypoglycemia and hyperglycemia and what to do if they occur. Patients with diabetes mellitus should carry a source of sugar (candy, sugar packets) and identification describing their disease and treatment regimen at all times. Emphasize the importance of regular follow-up, especially during first few weeks of therapy. Assessment Evaluation Why would you hold or not give this Check after giving med? Control of blood glucose Hypoglycemia, blood sugar within levels without the normal range. appearance of hypoglycemic or hyperglycemic episodes.

Related Documents

Novolin R (regular Insulin)
October 2019 27
Insulin Regular
June 2020 13
Novolin R
November 2019 25
Humulin R, Novolin R
November 2019 22

More Documents from ""

Zocor
October 2019 31
Albuterol Proventil
October 2019 37
Cymbalta
October 2019 40
Feosol[1]
October 2019 32